Metabolic profiling of Costello syndrome: Insights from a single-center cohort.
Biomarker
Costello syndrome
Hypoglycemia
Metabolism tracer
Personalized medicine
Journal
European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
08
10
2021
revised:
13
12
2021
accepted:
22
01
2022
pubmed:
2
2
2022
medline:
5
4
2022
entrez:
1
2
2022
Statut:
ppublish
Résumé
Costello syndrome (CS) is a rare disorder caused by activating dominantly acting germline variants in the HRAS gene. CS is defined by a clinical phenotype characterized by a distinctive gestalt, multiple congenital anomalies, and increased risk to develop tumors. Hypoglycemia and hypercholesterolemia have been reported to occur in affected individuals, but the underlying molecular events remain to be characterized. Here, we provided data on glucose/lipid metabolism and amino acid profile of a large single-center cohort of individuals affected by CS to systematically assess the extent of metabolic dysregulation characterizing this disorder and optimize patient management.
Identifiants
pubmed: 35101635
pii: S1769-7212(22)00020-9
doi: 10.1016/j.ejmg.2022.104439
pii:
doi:
Substances chimiques
Proto-Oncogene Proteins p21(ras)
EC 3.6.5.2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
104439Informations de copyright
Copyright © 2022 Elsevier Masson SAS. All rights reserved.